الأعمال والاقتصاد
Sainsbury’s and Morrisons ‘held talks this year’ on multibillion-pound merger
المصدر: Business | The Guardian · نُشر

Deal would have created a supermarket with a market share of 23.6%, still well behind Tesco’s 27.8% Sainsbury’s held merger talks with rival Morrisons this year to discuss a multibillion-pound deal that would have been the biggest shake-up for UK supermarkets in decades, accordin
Deal would have created a supermarket with a market share of 23.6%, still well behind Tesco’s 27.8% Sainsbury’s held merger talks with rival Morrisons this year to discuss a multibillion-pound deal that would have been the biggest shake-up for UK supermarkets in decades, according to reports. The two companies held exploratory negotiations, according to the Financial Times and Sky. It is believed they are no longer in live discussions.
Continue reading...
أخبار ذات صلة

BT agrees rescue deal to buy broadband operator TalkTalk
The takeover still needs to be approved by the regulator, but would give certainty to TalkTalk's millions of customers
feeds.bbci.co.uk ·

Why are data centres such a big deal in Scotland?
At least 23 huge data centres are planned in Scotland, causing significant concern for campaigners.
feeds.bbci.co.uk ·
Lucid's Q3 deliveries fall 6.7% as EV maker cuts production to align with demand
Lucid delivered 3,806 EVs and produced 2,954 vehicles during the third quarter. That compared with 4,078 deliveries on production of 3,891 vehicles a year earlier.
Business News ·

US supreme court hears big oil’s bid to block climate damage lawsuits
How court will lean is unclear amid Suncor Energy and ExxonMobil’s attempt to stop lawsuits at state level The US supreme court began its new nine-month term hearing arguments on Monday in a major case in which big oil companies attempted to strike a fatal blow against lawsuits t
Business | The Guardian ·
AstraZeneca CEO says Summit drug could drive next generation of cancer combinations after $2 billion investment
Pascal Soriot spoke exclusively with CNBC from the site of AstraZeneca's new $1 billion R&D facility in Kendall Square in Cambridge, Massachusetts.
Business News ·